Abstract
No public abstract is available from the verified source records.
Akın Calisir, Mustafa Sahin, Husnu Alptekin, Zeliha Esin Celik, Murat Çelik, Abdulkerim Kasim Baltaci
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Thyroid cancer incidence trends by histology in 25 countries: a population-based study
10.1016/s2213-8587(21)00027-9 · 2021
Evolving understanding of the epidemiology of thyroid cancer
10.1016/j.ecl.2018.10.002 · 2019
Cancer metastasis: building a framework
10.1016/j.cell.2006.11.001 · 2006
Cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018
Molecular insights into tumour metastasis: tracing the dominant events
10.1002/path.4871 · 2017
ZEB1 promotes oxaliplatin resistance through the induction of epithelial-mesenchymal transition in colon cancer cells
10.7150/jca.20952 · 2017
Overexpression of Chemokine (CXC) ligand 1 (CXCL1) associated with tumor progression and poor prognosis in hepatocellular carcinoma
10.1186/s12935-014-0086-8 · 2014
Regulation of Smad signaling through a differential recruitment of coactivators and corepressors by ZEB proteins
10.1093/emboj/cdg226 · 2003
ZEB1 expression is correlated with tumor metastasis and reduced prognosis of breast carcinoma in Asian patients
10.3109/07357907.2015.1022258 · 2015
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
The roles of the epithelial-mesenchymal transition marker PRRX1 and miR-146b-5p in papillary thyroid carcinoma progression
10.1016/j.ajpath.2014.04.011 · 2014
ZEB1 expression in endometrial biopsy predicts lymph node metastases in patient with endometrial cancer
10.1155/2014/680361 · 2014
Epithelial–mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer
10.1016/j.oraloncology.2012.07.012 · 2013
Zinc finger E-box-binding homeobox 1: its clinical significance and functional role in human thyroid cancer
2016
[Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]
1987
Significance of unphosphorylated and phosphorylated heat shock protein 27 as a prognostic biomarker in pancreatic ductal adenocarcinoma
10.1007/s00432-020-03175-0 · 2000
Unresolved referenced work
2017
8th edition of the AJCC/TNM staging system of thyroid cancer: what to expect (ITCO#2)
10.1530/erc-17-0453 · 2018
Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS)
10.1089/thy.2013.0317 · 2014
Cancer rate of Bethesda category II thyroid nodules
2022
The Bethesda System For Reporting Thyroid Cytopathology
10.1309/ajcpphlwmi3jv4la · 2009
The impact of implementation of the Bethesda System for Reporting Thyroid Cytopathology on the quality of reporting, ``risk'' of malignancy, surgical rate, and rate of frozen sections requested for thyroid lesions
10.1002/cncy.20174 · 2011
Patient outcomes following surgical management of thyroid nodules classified as Bethesda category III (AUS/FLUS)
10.5603/ep.a2021.0018 · 2021
Epithelial–mesenchymal transition in human cancer: comprehensive reprogramming of metabolism, epigenetics, and differentiation
10.1016/j.pharmthera.2015.01.004 · 2015
E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer
10.1007/s10555-008-9179-y · 2009
Transcription regulation of E-cadherin by zinc finger E-box binding homeobox proteins in solid tumors
10.1155/2014/921564 · 2014
Epithelial-mesenchymal transition as a fundamental mechanism underlying the cancer phenotype
10.1111/j.1476-5829.2011.00313.x · 2013
Expression of and correlation between BCL6 and ZEB family members in patients with breast cancer
2017
Pathological features of triple-negative breast cancers that showed progressive disease during neoadjuvant chemotherapy
10.1111/cas.13274 · 2017
ZEB1 promotes epithelial–mesenchymal transition in cervical cancer metastasis
10.1016/j.fertnstert.2015.03.016 · 2015
Predictive and prognostic value of ZEB1 protein expression in breast cancer patients with neoadjuvant chemotherapy
10.1186/s12935-019-0793-2 · 2019
Nuclear, cytoplasmic, and stromal expression of ZEB 1 in squamous and small cell carcinoma of the esophagus
10.1111/apm.12473 · 2015
Correlations of the ZEB1 expression with the incidence and prognosis of non-small cell lung cancer
2019
Zinc finger E-box-binding homeobox 1: its clinical significance and functional role in human thyroid cancer
2016
Prognostic factors in differentiated thyroid cancer revisited
2017
Influence of tumor number on clinicopathologic features and outcomes of patients with papillary thyroid carcinoma
10.1093/ajcp/aqaa102 · 2020
Prognosis of multifocal papillary thyroid carcinoma
10.1155/2013/809382 · 2013
Number of tumor foci predicts prognosis in papillary thyroid cancer
10.1186/1471-2407-14-914 · 2014
Patient and tumor factors contributing to distant metastasis in well-differentiated thyroid cancer: a retrospective cohort study
10.1186/s40463-020-00469-8 · 2020
ZEB1 expression is associated with prognosis of intrahepatic cholangiocarcinoma
10.1136/jclinpath-2015-203115 · 2016
Zinc finger E-box binding homeobox 1 promotes invasion and bone metastasis of small cell lung cancer in vitro and in vivo
10.1111/j.1349-7006.2012.02347.x · 2012
A comparison of surgical outcomes and complications between hemostatic devices for thyroid surgery: a network meta-analysis
10.1007/s00405-016-4190-3 · doi-reference
Thyroidectomy for the management of differentiated thyroid carcinoma and their outcome on early postoperative complications: a 6-year single-centre retrospective study
10.21614/chirurgia.2736 · doi-reference
Recurrence of papillary thyroid carcinoma from the residual pyramidal lobe: a case report and literature review
10.1097/md.0000000000015210 · doi-reference
Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis
10.1002/jso.23967 · doi-reference
The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer
10.1038/ncb3513 · doi-reference
Lymph node metastasis prediction of papillary thyroid carcinoma based on transfer learning radiomics
10.1038/s41467-020-18497-3 · doi-reference
The utility of routine preoperative cervical ultrasonography in patients undergoing thyroidectomy for differentiated thyroid cancer
10.1016/j.surg.2013.06.040 · doi-reference
Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer
10.1001/archsurg.141.5.489 · doi-reference
Surgeon-performed ultrasound in the management of thyroid malignancy
10.1177/000313480407000703 · doi-reference
The American Thyroid Association Guidelines Task Force on Thyroid nodules and differentiated Thyroid cancer
10.1089/thy.2015.0020 · doi-reference
Gene expression profiling of papillary thyroid carcinoma identifies transcripts correlated with BRAF mutational status and lymph node metastasis
10.1158/1078-0432.ccr-07-4372 · doi-reference
Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma
10.1245/s10434-012-2654-2 · doi-reference
Repression of E-cadherin by SNAIL, ZEB1, and TWIST in invasive ductal carcinomas of the breast: a cooperative effort?
10.1016/j.humpath.2010.05.019 · doi-reference
Locally advanced thyroid cancer
10.1097/01.moo.0000156161.82671.43 · doi-reference
Breach of the thyroid capsule and lymph node capsule in node-positive papillary and medullary thyroid cancer: different biology
10.1016/j.ejso.2014.10.049 · doi-reference
Thyroid cancer
10.1146/annurev-med-061512-105739 · doi-reference